10.26188/5bffd9504464a ADA CHEUNG ADA CHEUNG CHRISTOPHER CUNNINGHAM CHRISTOPHER CUNNINGHAM DONG-KYOON KO DONG-KYOON KO Vivian Ly Vivian Ly HANS GRAY HANS GRAY Rudolf Hoermann Rudolf Hoermann Boyd Strauss Boyd Strauss EBRAHIM BANI HASSAN EBRAHIM BANI HASSAN GUSTAVO DUQUE GUSTAVO DUQUE PETER EBELING PETER EBELING MARCUS PANDY MARCUS PANDY JEFFREY ZAJAC JEFFREY ZAJAC MATHIS GROSSMANN MATHIS GROSSMANN Supplementary Figures.docx The University of Melbourne 2018 muscle mass loss muscle forces androgen suppression Androgen Deprivation Therapy Prostate Cancer Cells Prostate cancer Medicine Endocrinology Motor Control 2018-11-29 12:20:04 Figure https://melbourne.figshare.com/articles/figure/Supplementary_Figures_docx/7398761 Supplementary Figures for Manuscript Titled "Selective loss of levator ani and leg muscle volumes in men undergoing androgen deprivation therapy." This is data from a case-control study comparing men newly commencing ADT and prostate cancer controls followed from baseline to 12 months. The primary outcome was muscle function outcomes. Supplementary Figure 1 shows the relationship between levator ani muscle volume change (x axis) and change in other androgen-sensitive parameters (y – axis i.e. hemoglobin, hematocrit, sexual function, fat mass and lean mass) from 12 to 0 months as a percentage forming an xy point each. Supplementary Figure 2 is a plot of pairs of muscle function change (y-axis) and muscle volume change (x-axis) from 12 to 0 months as a percentage forming an xy point each.